- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: IBI112
Total 86 results
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingUlcerative Colitis (UC)China
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Terminated
-
The First Affiliated Hospital of Zhengzhou UniversityNot yet recruitingEsophageal Squamous Cell Carcinoma (ESCC) | PD-1 InhibitorsChina
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingLocally Advanced Unresectable or Metastatic Solid TumorsAustralia
-
Innovent Biologics (Suzhou) Co. Ltd.TerminatedAdvanced Cutaneous Squamous Cell CarcinomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Solid TumorsChina
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruitingAdvanced Malignant TumorsChina
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Solid TumorsChina
-
Innovent Biologics (Suzhou) Co. Ltd.Terminated
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Peking UniversityInnovent Biologics (Suzhou) Co. Ltd.UnknownAdvanced Gastric or Gastroesophageal Junction (GEJ) AdenocarcinomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.Innovent Biologics (USA), Inc.WithdrawnMetastatic Cutaneous Melanoma | Unresectable Cutaneous MelanomaUnited States, Germany, France, Australia, Spain, Switzerland, United Kingdom
-
NightstaRx Ltd, a Biogen CompanyCompletedX-Linked Retinitis PigmentosaUnited States, France, United Kingdom, Finland, Netherlands, Germany, Canada
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingThyroid Eye Disease, TEDChina
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruitingOverweight/ ObesityChina
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedNSCLC (Non-small-cell Lung Cancer)China
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Solid TumorChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingAdvanced Biliary Tract CancerChina
-
BiogenCompletedX-Linked Retinitis PigmentosaUnited States, United Kingdom
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Solid TumorChina
-
Immune Biosolutions IncCompleted
-
Peking University People's HospitalActive, not recruitingThyroid Associated OphthalmopathyChina
-
Innovent Biologics (Suzhou) Co. Ltd.TerminatedCOVID-19United States
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Solid TumorChina
-
Immune Biosolutions IncCompletedCOVID-19South Africa, Ukraine
-
Hunan Province Tumor HospitalRecruitingNon-Small Cell Lung CancerChina
-
Peking UniversityRecruitingNeuroendocrine NeoplasmChina
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced MalignanciesChina
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Solid TumorsChina